Other name for perjeta
WebFeb 1, 2024 · Description and Brand Names. Drug information provided by: IBM Micromedex. US Brand Name. Perjeta; Descriptions. Pertuzumab injection is used to treat breast cancer that has spread to other parts of the body. It is used together with other cancer medicines (eg, docetaxel, trastuzumab) to treat patients with HER2-positive breast cancer. WebPlease complete the form below if you would like a Genentech Breast Therapeutic Area Manager to contact you regarding your PERJETA information request. You should receive a response within 2 business days. Your contact information will not be used for any other purpose than for the representative to respond to your information request.
Other name for perjeta
Did you know?
WebPerjeta (chemical name: pertuzumab) used in combination with Herceptin (chemical name: trastuzumab), another targeted therapy medicine, and Taxotere (chemical name: docetaxel), a type of chemotherapy, to treat HER2-positive, metastatic breast cancer that hasn’t been treated with either Herceptin or chemotherapy yet. WebThe generic name of Perjeta is pertuzumab. The product's dosage form is injection, solution, concentrate and is administered via intravenous form. The product is distributed in a single package with assigned NDC code 50242-145-01 1 vial, single-use in 1 carton / 14 ml in 1 vial, single-use. This page includes all the important details about ...
WebDec 1, 2015 · Pertuzumab (trade name: Perjeta) has been approved in Germany since July 2015 for the treatment of HER2-positive, locally advanced, inflammatory, or early breast … WebPertuzumab, sold under the brand name Perjeta, is a monoclonal antibody used in combination with trastuzumab and docetaxel for the treatment of metastatic HER2-positive breast cancer; it also used in the same combination as a neoadjuvant in early HER2-positive breast cancer.. Side effects in more than half the people taking it include diarrhea, hair …
http://www.bccancer.bc.ca/drug-database-site/Drug%20Index/Pertuzumab_handout_1Jan2014.pdf WebHerceptin Alternatives Compared. Prescribed for Breast Cancer, Breast Cancer - Metastatic, Breast Cancer - Adjuvant, Esophageal Carcinoma, Gastric Cancer. May also be prescribed …
WebWhat it is used for. Early Breast Cancer Perjeta is indicated in combination with trastuzumab and chemotherapy for:,- the neoadjuvant treatment of patients with HER2-positive …
WebWhat it is used for. Early Breast Cancer Perjeta is indicated in combination with trastuzumab and chemotherapy for:,- the neoadjuvant treatment of patients with HER2-positive inflammatory or locally advanced, or early stage (either > 2 cm in diameter or node positive) breast cancer as part of a complete treatment regimen for early breast cancer ... born coverWebDiarrhea. Nausea. Hair Loss. Feeling tired. Damage to the nerves (numbness, tingling, pain in hands/feet) Vomiting. The most common side effects of PERJETA when given with Herceptin and docetaxel for treatment of breast cancer that has spread to other parts of the body (metastatic) are: Diarrhea. Hair loss. born creative campPertuzumab, sold under the brand name Perjeta, is a monoclonal antibody used in combination with trastuzumab and docetaxel for the treatment of metastatic HER2-positive breast cancer; it also used in the same combination as a neoadjuvant in early HER2-positive breast cancer. Side effects in more than half the … See more Pertuzumab is administered as an intravenous infusion in combination with trastuzumab and docetaxel as a first line treatment for HER2-positive metastatic breast cancer. It is also used in the same combination as a See more In clinical trials of the three-agent combination therapy in metastatic breast cancer, adverse effects occurring in more than half the people … See more HER2 is an extracellular receptor—a receptor tyrosine kinase - that when activated, sets off signal transduction through See more The monoclonal antibody 2C4 appears to have first been published in 1990 by scientists from Genentech, the same year that F. Hoffmann-La Roche AG acquired a majority stake in Genentech. By 2003, Genentech understood that 2C4 prevented HER2 … See more The metabolism of pertuzumab has not been directly studied; in general antibodies are cleared principally by catabolism. The median clearance of pertuzumab was 0.235 liters/day and the median half-life was 18 days. See more Pertuzumab is an immunoglobulin G1 with a variable region against the human HER2 protein, a human-mouse monoclonal 2C4 heavy chain, disulfide bound with a human-mouse … See more Economics As of 2016 , in the US each cycle of the three-drug combination given every three weeks costs around … See more born cove waterproofWebLoading dose: Infuse over 60 minutes Subsequent doses: Infuse over 30-60 minutes. Monitor for infusion related adverse effects (eg, hypersensitivity, pyrexia, chills, headache, … born craft and createWebIf you notice other effects not listed above, contact your doctor or pharmacist. In the US - Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA ... haven caravans for sale lake districtWebSep 27, 2024 · Perjeta (pertuzumab) is a monoclonal antibody treatment for breast cancer. The name Perjeta was created from combining the prefix /PER/ (from pertuzumab) together with /JET/, a metaphor for speed of recovery. The final /A/ creates a feminine tone, aligning the brand name with its female patient population. haven caravans at cleethorpesWebMay 23, 2024 · Wash soiled clothing and linens separately from other laundry. Perjeta side effects. Get emergency medical help if you have signs of an allergic reaction to Perjeta: … born cove modern sandals